Drug Shortage Report for MEPERIDINE HYDROCHLORIDE INJECTION USP

Last updated on 2023-03-14 History
Report ID 179609
Drug Identification Number 00725765
Brand name MEPERIDINE HYDROCHLORIDE INJECTION USP
Common or Proper name MEPERIDINE HCL
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) MEPERIDINE HYDROCHLORIDE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR
Packaging size 1ML
ATC code N02AB
ATC description OPIOIDS
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2022-12-28
Estimated end date 2023-03-24
Actual end date 2023-03-13
Shortage status Resolved
Updated date 2023-03-14
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2023-03-14 English Compare
v9 2023-03-13 French Compare
v8 2023-03-13 English Compare
v7 2023-03-06 French Compare
v6 2023-03-06 English Compare
v5 2023-02-14 French Compare
v4 2023-02-14 English Compare
v3 2022-12-29 English Compare
v2 2022-12-28 French Compare
v1 2022-12-28 English Compare

Showing 1 to 10 of 10